BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
0.9665
+0.0464 (5.04%)
Oct 19, 2026, 10:58 AM EDT - Market open
BioCardia Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 4.12 | 2.5 | 2.37 | 1.1 | 7.36 | 12.87 |
Cash & Short-Term Investments | 4.12 | 2.5 | 2.37 | 1.1 | 7.36 | 12.87 |
Cash Growth | 320.10% | 5.27% | 114.96% | -85.02% | -42.80% | -39.87% |
Accounts Receivable | 0.03 | 0.02 | - | 0.06 | 0.2 | 0.15 |
Receivables | 0.03 | 0.02 | - | 0.06 | 0.2 | 0.15 |
Prepaid Expenses | 0.15 | 0.22 | 0.25 | 0.3 | 0.3 | 0.46 |
Total Current Assets | 4.3 | 2.73 | 2.62 | 1.46 | 7.86 | 13.48 |
Property, Plant & Equipment | 0.29 | 0.51 | 0.93 | 1.36 | 1.76 | 2.07 |
Other Long-Term Assets | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 |
Total Assets | 4.76 | 3.41 | 3.72 | 2.99 | 9.79 | 15.72 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.54 | 0.64 | 0.39 | 0.89 | 0.68 | 0.51 |
Accrued Expenses | 0.68 | 0.81 | 1.02 | 1.75 | 1.6 | 1.44 |
Current Portion of Leases | 0.29 | 0.44 | 0.39 | 0.33 | 0.32 | 0.24 |
Current Unearned Revenue | 0.47 | 0.47 | 0.47 | 0.47 | 0.88 | 1.44 |
Other Current Liabilities | 0.06 | 0.06 | 0.06 | 0.16 | 0.11 | 0.1 |
Total Current Liabilities | 2.06 | 2.43 | 2.32 | 3.61 | 3.59 | 3.71 |
Long-Term Leases | - | 0.09 | 0.57 | 0.98 | 1.32 | 1.63 |
Total Liabilities | 2.06 | 2.52 | 2.89 | 4.59 | 4.9 | 5.34 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.02 | 0.01 | 0.01 | 0 | 0.02 | 0.02 |
Additional Paid-In Capital | 174.91 | 169.23 | 160.95 | 150.57 | 145.48 | 139.06 |
Retained Earnings | -172.22 | -168.35 | -160.12 | -152.18 | -140.6 | -128.7 |
Total Common Equity | 2.7 | 0.9 | 0.84 | -1.6 | 4.89 | 10.38 |
Shareholders' Equity | 2.7 | 0.9 | 0.84 | -1.6 | 4.89 | 10.38 |
Total Liabilities & Equity | 4.76 | 3.41 | 3.72 | 2.99 | 9.79 | 15.72 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.29 | 0.53 | 0.95 | 1.32 | 1.63 | 1.87 |
Net Cash (Debt) | 3.82 | 1.97 | 1.42 | -0.21 | 5.73 | 11 |
Net Cash Growth | 1527.23% | 38.59% | - | - | -47.91% | -47.08% |
Net Cash Per Share | 0.38 | 0.30 | 0.52 | -0.15 | 4.85 | 9.76 |
Filing Date Shares Outstanding | 15.14 | 10.94 | 4.68 | 1.78 | 1.35 | 1.12 |
Total Common Shares Outstanding | 14.98 | 10.76 | 4.6 | 1.58 | 1.34 | 1.12 |
Working Capital | 2.24 | 0.3 | 0.3 | -2.15 | 4.28 | 9.77 |
Book Value Per Share | 0.18 | 0.08 | 0.18 | -1.02 | 3.65 | 9.22 |
Tangible Book Value | 2.7 | 0.9 | 0.84 | -1.6 | 4.89 | 10.38 |
Tangible Book Value Per Share | 0.18 | 0.08 | 0.18 | -1.02 | 3.65 | 9.22 |
Machinery | 0.78 | 0.78 | 0.77 | 0.76 | 0.76 | 0.62 |
Construction In Progress | - | - | - | - | - | 0.07 |
Leasehold Improvements | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |